Influence of Gut Metabolites on Bone Mineralization and Remodeling: Effects of Metabolic Dysregulation on the Gut-Immune-Bone Interaction - Top-Institutions - MDSpire

Influence of Gut Metabolites on Bone Mineralization and Remodeling: Effects of Metabolic Dysregulation on the Gut-Immune-Bone Interaction

  • By

  • Sanjay Basak

  • Kota Sri Naga Hridayanka

  • Asim K. Duttaroy

  • April 28, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Metabolic Bone Disease
    • Microbiome Research

  • #2

    Harvard Medical School / Massachusetts General Hospital
    Harvard Medical School / Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Immunology
    • Metabolomics

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Bone Metabolism
    • Microbiome Research
    • Endocrinology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Microbiome
    • Bone Biology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Metabolic Bone Disease
    • Endocrinology
    • Microbiome Research

Original Source(s)

Influence of Gut Metabolites on Bone Mineralization and Remodeling: Effects of Metabolic Dysregulation on the Gut-Immune-Bone Interaction

  • by Sanjay Basak, Kota Sri Naga Hridayanka, Asim K. Duttaroy

  • April 28, 2026

Related Content

Current Insights into Osteoporosis Linked to Endocrine Disorders

Association of Bone Mass, Falls, and Vertebral Fractures in Older Patients on Hemodialysis: The Role of Comprehensive Geriatric Assessment

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing